首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >A highly sensitive assay of human plasma xanthine oxidoreductase activity using stable isotope-labeled xanthine and LC/TQMS
【24h】

A highly sensitive assay of human plasma xanthine oxidoreductase activity using stable isotope-labeled xanthine and LC/TQMS

机译:使用稳定的同位素标记的黄嘌呤和LC / TQMS对人血浆黄嘌呤氧化还原酶活性进行高灵敏度测定

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Associations between elevated plasma xanthine oxidoreductase (XOR) activity and various pathologies have been widely reported. However, it has been difficult to accurately measure human plasma XOR activity because the XOR activity of humans is lower than that of animals such as mouse. We developed a highly sensitive assay for XOR activity utilizing a combination of [C-13(2),N-15(2)] xanthine and liquid chromatography/triple quadrupole mass spectrometry. In the present study, we established and validated a novel human plasma XOR activity assay utilizing this technique. The calibration curve of [C-13(2),N-15(2)]uric acid showed linearity over the range of 4-4000 nM (r(2) > 0.995) with a lower limit of quantitation of 4 nM which corresponds to an XOR activity of 6.67 pmol/h/mL plasma. Intra- and inter-assay coefficients of variation of pooled human plasma XOR activity were 6.5% and 9.1%, respectively. Plasma XOR activities of 20 healthy volunteers ranged from 32.8 to 227 pmol/h/mL (mean +/- SD = 89.1 +/- 55.1, n = 20), which correlated with alanine transaminase (r= 0.827), aspartate transaminase (r = 0.487), and uric acid (r= 0.502). The established assay is expected to be useful for investigating the function of XOR and the effect of its inhibitors in various diseases. (C) 2016 Elsevier B.V. All rights reserved.
机译:血浆黄嘌呤氧化还原酶(XOR)活性升高与各种病理之间的关联已被广泛报道。然而,由于人的XOR活性低于诸如小鼠的动物的XOR活性,因此难以精确地测量人血浆的XOR活性。我们使用[C-13(2),N-15(2)]黄嘌呤和液相色谱/三重四极杆质谱联用开发了XOR活性的高灵敏度检测方法。在本研究中,我们建立并验证了利用这种技术的新型人血浆XOR活性测定法。 [C-13(2),N-15(2)]尿酸的校准曲线在4-4000 nM范围内显示线性(r(2)> 0.995),定量下限为4 nM,对应至血浆的XOR活性为6.67 pmol / h / mL。合并的人血浆XOR活性的测定内和测定间变异系数分别为6.5%和9.1%。 20名健康志愿者的血浆XOR活性范围为32.8至227 pmol / h / mL(平均+/- SD = 89.1 +/- 55.1,n = 20),与丙氨酸转氨酶(r = 0.827),天冬氨酸转氨酶(r = 0.487)和尿酸(r = 0.502)。建立的检测方法有望用于研究XOR的功能及其抑制剂在各种疾病中的作用。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号